You are here: Industry Insights > drug

News List

NASH: Seizing Opportunities in the Untapped Market Neeta Ratanghayra
April 23, 2020
Nonalcholic steatohepatitis (NASH) is a hard to diagnose liver disease, characterized by steatosis, chronic inflammation, and progressive fibrosis that may lead to cirrhosis, liver failure. NASH is also a significant risk factor for the development of hep
IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation PharmaSources
March 10, 2023
The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker assay.
US healthcare groups publish drug supply chain recommendations EuropeanPharmaceuticalReview
December 23, 2021
American healthcare groups have released a series of policy and marketplace recommendations to address significant challenges in the US drug supply chain.
Press Release Eupraxia Pharmaceuticals Announces Filing of Preliminary Base Shelf Prospectus FirstWordPharma
December 14, 2021
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that it has filed and obtained a receipt for a preliminary short form...
NewsPoints Former DEA official helped pharma company get drug quota increase, says watchdog FirstWordPharma
December 03, 2021
According to the US Justice Department's internal watchdog, a former senior official at the Drug Enforcement Administration (DEA) improperly gave preferential treatment to a pharmaceutical company that was seeking a quota increase so it could...
Vice-premier stresses accelerating COVID-19 drug research NMPA
October 21, 2021
BEIJING — Vice-Premier Sun Chunlan has urged more efforts to accelerate the research and development of COVID-19 drugs and strive for breakthroughs so as to safeguard people's health.
Expiry and shelf life of drug products expresspharma
February 24, 2021
Do we know whose prime concern is it to have a reasonable shelf life, moderate storage conditions and long expiration periods of the drug products? None other than the manufacturers, and in turn, the people who develop the products.
Open innovation in drug development expresspharma
December 28, 2020
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca shares insights on how greater transparency in drug development could deliver quicker, more affordable solutions.
EIB launches €50m Africa pharmaceutical manufacturing initiative pharmaceutical-business-review
December 23, 2020
The European Investment Bank launched the first ever scheme to strengthen local production of Active Pharmaceutical Ingredients in Africa and scale up drug manufacturing essential to improve public health.
Indian researchers find new potential COVID-19 drug treatments expresspharma
December 11, 2020
One proposed cocktail, baloxavir marboxil, natamycin and RU85053, targets three viral proteins respectively, 3CL Main protease, papain-like protease and RdRp.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page